A new federal commission will ‘investigate’ decades-old mental health as well as weight loss drugs, prompting concerns from ...
FDA-approved drugs are also often patented and subject to various laws regarding exclusivity for a given manufacturer. At the ...
If drug tariffs don’t work, they could result in higher prices for American patients and increase drug shortages. Testing ...
Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...
The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...
Sooma Medical has received the approval of an investigational device exemption (IDE) from the US Food and Drug Administration ...
Mía had dystrophic epidermolysis bullosa, better known as butterfly skin due to the extreme fragility of this tissue in ...
Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results